Category: Research

The Biobanking Consensus Meeting, initiated by us, is being held at Islington’s Business Design Centre in London.

Researchers from Toronto and Montreal have successfully identified three distinct sub-groups of classification of the incurable typical teratoid rhabdoid tumours (ATRTs).

In order to ensure that we fund only the highest quality research, we have formed two Scientific Advisory Boards (SABs) which are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science.

Researchers at the University of Texas Southwestern Medical Center in Dallas have identified a gene called SHOX2 that could be used to better diagnose brain tumours.

“We will always do things differently if it’s the right thing for people affected by a brain tumour. That’s why we’re investing in The Brain Tumour Fund.” – Sarah Lindsell, CEO of The Brain Tumour Charity

Research carried out at the University of Edinburgh has revealed a new alliance between immune cells and glioblastoma tumour cells in zebrafish.

A battery-powered cap that disrupts the growth of brain tumour cells could help glioblastoma patients to survive for longer, new findings suggest.

The Paediatric Brain Tumor Atlas Project has been launched by Cancer MoonShot 2020.

We caught up with Dr Paul Brennan from the University of Edinburgh to hear more about his research.

The new Seimens Magnetom Terra 7 Tesla MRI machine is being installed in Glasgow in March 2017.

Professor Richard Gilbertson, tells us about his move to The Cambridge Cancer Centre and his plans for the future or brain tumour research

Dr Colin Watts’ research, funded by us, uses fluorescent dye to reveal different parts of glioblastoma tumours during surgery.

Researchers want to gather tissue samples from people with high-grade brain tumours as part of the groundbreaking Genomics England programme.

New research prompts drive to increase specialist neurosurgery access

The latest report from the Association of Medical Research Charities (AMRC) shows that we’re part of an annual investment worth more than £1 billion each year amounting to over 40% of all publically-funded medical research.

12-year-old Ollie Gardiner is set to become one of the first patients in the world to receive a treatment being trialled for childhood brain tumour patients after an astonishing fundraising campaign launched by his family.

US doctors are testing a new glioblastoma drug treatment with early results looking positive.

Microsoft has vowed to “solve the problem of cancer” within a decade by using ground-breaking computer science.

Brain cancer has surpassed leukemia as the deadliest cancer for children and teens in the United States, according to new government data reports the CNN news channel.

The Francis Crick Institute has just opened next to St Pancras station and the British Library.

Dr Francis Ali-Osman has been appointed to advise the Government on a wide range of issues relating to the US national cancer programme.

The Artificial Intelligence (AI) division of Google based in London, DeepMind, will attempt to differentiate between healthy and cancerous tissue by analysing 700 CT and MRI scans from former University College London patients.

Stroud-based manufacturing company Renishaw, have installed revolutionary technology at King’s College London that dramatically improves accuracy and patient outcomes.

Scientists from The Wistar Institute in Philadelphia, have discovered how glioma tumour cells adapt to low-oxygen environments in the brain allowing them to continue to grow.